Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bd4e87ecbca17f16d460ca394e60f9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
filingDate |
2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300f262109a5ded69797a47e6549e6aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dff4f0e31f435ecf8213806d0c628bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a82caf2b08e739e5c971fe7aa2928ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c37282bfdf2c504f89158218df7aee36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ff898c854daa7b1b05e648baf0c716 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ebafa6052558578b4200d7f2a3cca36 |
publicationDate |
2019-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014273226-B2 |
titleOfInvention |
Tamper resistant dosage form with bimodal release profile |
abstract |
The invention relates to a pharmaceutical dosage form comprising: (i) at least one formed segment (S |
priorityDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |